Israel National Biotech Innovation Center (INBI) launches with Anat Cohen-Dayag as CEO of INBI Core
INBI aims to advance Israeli biomedical research and accelerate the development of new therapies, bringing together 15 Israeli research institutions and medical centers to help move scientific research toward new medicines
Assessment
Israel is consolidating its biomedical research under one roof. The new center pulls together 15 research institutions and medical centers, which suggests a coordinated push to turn academic findings into actual therapies faster. Anat Cohen-Dayag takes the CEO role at INBI Core, the operational arm. The real test will be whether this structure shortens the path from lab discovery to patient treatment, and whether the institutions actually collaborate rather than compete. Watch for the first concrete projects and funding commitments.